|
Recent News
GelStat Announces the Retention of WSR Consulting, Inc. to Lead Its Corporate Financial Initiatives
BLOOMINGTON, MN--(MARKET WIRE)--Apr 3, 2008 -- GelStat Corporation (Other OTC:GSAC.PK - News) is
pleased to announce that it has retained the services of
WSR Consulting,
Inc. (a Wall Street Resources Company). GelStat is a consumer
healthcare
company focused on the development and marketing of over-the-counter
(OTC)
products for the safe and effective treatment of pain and
inflammation.
WSR Consulting has been retained to lead an effort to manage
all financial
operations. Initially, the focus will be to bring the Company's
financial
records up-to-date, compile future quarterly and year-end
financial
statements (according to the schedule for fully reporting
companies) and
prepare for an audit for years ending 2005, 2006 and 2007.
WSR will also
manage M&A activities.
To implement these initiatives, WSR Consulting's principals
will work
closely with GelStat's executive management team, board
of directors and
GelStat's marketing consultants (U.S. Marketing, Ltd) to
increase its
transparency with the investment community and build shareholder
value.
Future plans and accomplishments will be communicated through
press
releases, conferences calls and quarterly financial reports.
Furthermore,
WSR Consulting has agreed to accept 144 restricted stock
as its entire
compensation for its 12-month engagement. Adrian G. Goldfarb,
co-founder
and President of WSR Consulting stated, "We want to send
a signal to the
financial community that we believe in the future of GelStat.
To make that
message loud and clear we have agreed to 100% equity compensation.
Our
incentive is clearly aligned with GelStat's investors to
build long-term
shareholder value." Bill Colucci, President of GelStat, stated, "We are pleased
to be working
with WSR Consulting at this phase of the Company's transformation
and
welcome the addition of experienced personnel to our team.
It is our
belief that this team will assist us in moving GelStat Corporation
forward." WSR Consulting's principals bring to GelStat over 50 years
of combined
experience in accounting, executive management, strategic
planning and
corporate financial experience. They also have experience
in international
business to assist with the planned expansion into those
markets. The
following are brief bios of the primary consultants that
will be working
with the Company. Adrian G. Goldfarb - Co-Founder/President, WSR Consulting,
Inc. Mr. Goldfarb has more than 25 years experience in a number
of different
technology companies including IBM and a Fujitsu subsidiary.
In addition to
extensive international experience in a variety of management
roles, he
served as General Manager for the European affiliate of
The Weather Channel
and was responsible for turning around its European operations
after
multiple years of losses under previous management. He has
most recently
been involved in the private equity space, both as a management
consultant
and investor and recently concluded the sale of one of those
companies to a
large European investment group. Mr. Goldfarb specializes
in the turnaround
and growth of emerging companies with a focus on strategic
planning and
prudent financial management. Mr. Goldfarb is a graduate
of Rutgers
University in New Jersey with a BA in Business Administration
specializing
in Finance. Gerald N. Kieft - Co-Founder, WSR Consulting, Inc. Mr. Kieft is the founder and President of Wall Street Resources,
Inc. and a
co-founder of WSR Consulting, Inc. Mr. Kieft began his career
in the
finance industry as an analyst for the Loan Source in 1991,
providing
debt-funding sources for small businesses through Small
Business
Association (SBA) loans. Subsequently, Mr. Kieft has worked
as a buy-side
analyst for a hedge fund, a sell-side analyst for a boutique
brokerage firm
and as a consultant to high net worth individuals and emerging
growth
companies at a number of financial institutions including
Prudential
Securities, Legg Mason Wood Walker and Raymond James &
Associates.
Throughout his career in the finance industry, Mr. Kieft
has helped
numerous emerging growth companies obtain financing and
gain market
awareness, while providing quality information on micro
and small capital
companies to the investment community. Mr. Kieft is a graduate
of Eastern
Illinois University, where he earned a Bachelor of Science
in Business
degree, majoring in Finance, as well as a Bachelor of Arts
degree, majoring
in Economics. Michael R. Hull, CPA - Managing Director - CFO Services,
WSR Consulting,
Inc. Mr. Hull joined WSR Consulting, Inc. in 2008 as its Managing
Director of
CFO Services. After graduating from college, Mr. Hull spent
11 years
auditing both public and private companies for Price Waterhouse,
advancing
from audit staff to audit senior manager. Upon leaving Price
Waterhouse, he
accepted the position of CFO for BCT International, a public
company that
is a franchisor of wholesale printing businesses with annual
network sales
of $107 million. Subsequently, he worked for Resources Global
Professionals, where he was a member of a team that assisted
a $4 billion
subsidiary of a $40 billion multinational company in complying
with Section
404 of the Sarbanes Oxley Act of 2002. Most recently, Mr.
Hull served as
the CFO of BabyUniverse, a public company traded on Nasdaq.
His
responsibilities included preparing the annual 10-K and
quarterly 10-Qs
filed with the SEC and coordinated the annual financial
statement audit and
quarterly reviews. Mr. Hull is a 1985 graduate of the University
of
Central Florida with a B.S.B.A. in Accounting. He has been
a Certified
Public Accountant since 1986 and is a member of the Florida
Institute of
Certified Public Accountants, a member of the American Institute
of
Certified Public Accountants, and a member of the Financial
Executives
Network Group. Ronnie Sue Goldfarb, R. N. - Operations Manager, WSR Consulting,
Inc. Ms. Goldfarb began her nursing career at a large medical
center as a staff
nurse. She has held positions at Squibb Pharmaceutical,
FHP Health Care, a
large California insurance company which is now a United
Health Care
company and a European division of Abbott Laboratories.
Most recently, she
was a Disease Management Coordinator at a large Florida
health insurance
company where she was involved with the establishment of
their Disease
Management program. Ms. Goldfarb is a graduate of The University
of
Vermont School of Nursing with a Bachelor's of Science in
Nursing.
Currently, Ms. Goldfarb holds her RN License in the state
of Florida.
Previously, she has held licenses in New Jersey, Virginia,
California and
the United Kingdom. ABOUT WSR CONSULTING, INC. WSR Consulting, Inc. is a diversified business development
and corporate
financial management company that provides emerging growth
companies with
interim CFO and COO executive services, SEC filing support
and Section 404
C compliance. ABOUT GELSTAT CORPORATION GelStat Corporation is dedicated to providing safe and effective
over-the-counter (OTC) treatments for pain and inflammation.
GelStat's
first product, GelStat Migraine, is sold through retail
chain stores,
independent retailers and pharmacies, and direct to consumer
channels.
GelStat Migraine is a sublingually (under the tongue) administered
OTC
medication for acute relief from the pain and associated
symptoms of
migraine. Over 90 percent of the 30 million Americans with
migraine use OTC
headache remedies, generally aspirin or other non-steroidal
anti-inflammatory drugs. Americans spend $2.6 billion each
year on 600
million units of such products, although they are believed
to be effective
for only about 25 percent of those with moderate to severe
migraine. The Company also has a suite of additional, effective healthcare
products
that address large consumer markets. GelStat(TM) Arthritis
is the second
available product to utilize GelStat's patent-pending formulation
and is
provided as a daily use, sublingual dissolving tablet. The
Center for
Disease Control estimates that, in its many forms, arthritis
affects up to
70 million Americans. The Company has also developed "GelStat(TM)
Sinus"
and "GelStat(TM) Sleep," and believes that each of these
products performs
well and is effective for its intended use. The National
Institute of
Allergy and Infectious Disease estimates that 37 million
Americans are
affected by sinusitis every year, with at least 20 million
more suffering
from allergies. Approximately 70 million Americans are reported
to be
"problem sleepers." For more information, visit www.gelstat.com Safe Harbor Statement Under the Private Securities Litigation
Act of 1995 With the exception of historical information, the matters
discussed in this
press release are forward-looking statements that involve
a number of risks
and uncertainties. The actual future results of GelStat
could differ
significantly from those statements. Factors that could
cause actual
results to differ materially include risks and uncertainties
such as the
inability to finance the company's operations or expansion,
inability to
hire and retain qualified personnel, changes in the general
economic
climate, including rising interest rate and unanticipated
events such as
terrorist activities. In some cases, you can identify forward-looking
statements by terminology such as "may," "will," "should,"
"expect,"
"plan," "anticipate," "believe," "estimate," "predict,"
"potential," or
"continue," the negative of such terms, or other comparable
terminology.
These statements are only predictions. Although we believe
that the
expectations reflected in the forward-looking statements
are reasonable,
such statements should not be regarded as a representation
by the Company,
or any other person, that such forward-looking statements
will be achieved.
We undertake no duty to update any of the forward-looking
statements,
whether as a result of new information, future events or
otherwise. In
light of the foregoing, readers are cautioned not to place
undue reliance
on such forward-looking statements. For further risk factors,
please review
our SEC filings. |